During the recent session, Abbvie Inc (NYSE:ABBV)’s traded shares were 1.41 million, with the beta value of the company hitting 0.49. At the last check today, the stock’s price was $184.85, reflecting an intraday loss of -0.34% or -$0.64. The 52-week high for the ABBV share is $218.66, that puts it down -18.29 from that peak though still a striking 11.54% gain since the share price plummeted to a 52-week low of $163.52. The company’s market capitalization is $326.53B, and the average intraday trading volume over the past 10 days was 4.39 million shares, and the average trade volume was 7.64 million shares over the past three months.
Abbvie Inc (ABBV) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.87. ABBV has a Sell rating from 0 analyst(s) out of 27 analysts who have looked at this stock. 7 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 20 recommend a Buy rating for it.
Abbvie Inc (NYSE:ABBV) trade information
Abbvie Inc (ABBV) registered a -0.34% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -0.34% in intraday trading to $184.85, hitting a weekly high. The stock’s 5-day price performance is -3.93%, and it has moved by 0.00% in 30 days. Based on these gigs, the overall price performance for the year is 8.94%. The short interest in Abbvie Inc (NYSE:ABBV) is 15.89 million shares and it means that shorts have 2.19 day(s) to cover.
The consensus price target of analysts on Wall Street is $217.5, which implies an increase of 15.01% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $215 and $220 respectively. As a result, ABBV is trading at a discount of -19.02% off the target high and -16.31% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -14.67%. While earnings are projected to return 20.82% in 2025, the next five years will return 15.22% per annum.
ABBV Dividends
Abbvie Inc is due to release its next quarterly earnings on 2025-Apr-25. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance. Investors should also take the other fundamental and operational aspects into account before investing in the stock. The forward dividend ratio for Abbvie Inc is 6.38, with the dividend yield indicating at 3.45 percent, continuing the trend of increasing dividends in recent years. The average dividend yield of the company for the last 5 years is 3.93%.
Abbvie Inc (NYSE:ABBV)’s Major holders
Abbvie Inc insiders own 0.10% of total outstanding shares while institutional holders control 74.45%, with the float percentage being 74.53%. VANGUARD GROUP INC is the largest shareholder of the company, while 4674.0 institutions own stock in it. As of 2024-06-30, the company held over 170.66 million shares (or 9.6472% of all shares), a total value of $29.27 billion in shares.
The next largest institutional holding, with 136.43 million shares, is of BLACKROCK INC.’s that is approximately 7.7124% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $23.4 billion.
